Kochan J, Murialdo H
Virology. 1983 Nov;131(1):100-15. doi: 10.1016/0042-6822(83)90537-8.
The morphogenesis of bacteriophage lambda proheads is under the control of the four phage genes B, C, Nu3, and E, as well as the E. coli genes groEL and groES. It has been previously shown that extracts prepared from cells infected with a lambda C-E- mutant accumulate biologically active gpB and gpNu3 (Murialdo, H., and Becker, A., J. Mol. Biol. 125, 57-74 (1978) ). To characterize the nature of these intermediates in prohead assembly, extracts prepared from these cells were fractionated by DEAE-cellulose chromatography as well as velocity sedimentation. Intermediates containing gpB were identified by SDS-polyacrylamide gel electrophoresis and by their ability to be assembled into biologically active proheads in vitro. The results indicate that the most abundant, biologically active intermediate (greater than 98% of the gpB activity) is a 25 S gpB-containing polymer. A second biologically active intermediate (about 1% of the total gpB activity) was identified as a gpB-gpgroEL complex.
噬菌体λ原头部的形态发生受四个噬菌体基因B、C、Nu3和E以及大肠杆菌基因groEL和groES的控制。先前已经表明,用λ C-E-突变体感染的细胞制备的提取物积累了具有生物活性的gpB和gpNu3(穆里亚尔多,H.,和贝克尔,A.,《分子生物学杂志》125,57 - 74(1978))。为了表征原头部组装中这些中间体的性质,从这些细胞制备的提取物通过DEAE - 纤维素色谱以及速度沉降进行分级分离。含有gpB的中间体通过SDS - 聚丙烯酰胺凝胶电泳以及它们在体外组装成具有生物活性的原头部的能力来鉴定。结果表明,最丰富的具有生物活性的中间体(大于98%的gpB活性)是一种含25 S gpB的聚合物。第二种具有生物活性的中间体(约占总gpB活性的1%)被鉴定为gpB - gpgroEL复合物。